Evidence map›Paper›PMID 31573887›Full record

ReviewCurrent neuropharmacology2020

Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR.

Angeles Edith Espino-Saldaña, Roberto Rodríguez-Ortiz, Elizabeth Pereida-Jaramillo, Ataúlfo Martínez-Torres

Abstract readReview
In one paragraph

Review in Current neuropharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Mutants of the Zebrafish KInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Angeles Edith Espino-SaldañaDepartamento de Neurobiologia Celular y Molecular, Laboratorio de Neurobiologia Molecular y Celular, Instituto de Neurobiologia, Campus UNAM Juriquilla, Queretaro, Qro CP76230, Mexico.
Roberto Rodríguez-OrtizCONACYT - Instituto de Neurobiologia, Universidad Nacional Autonoma de Mexico. Queretaro, Qro, Mexico.
Elizabeth Pereida-JaramilloDepartamento de Neurobiologia Celular y Molecular, Laboratorio de Neurobiologia Molecular y Celular, Instituto de Neurobiologia, Campus UNAM Juriquilla, Queretaro, Qro CP76230, Mexico.
Ataúlfo Martínez-TorresDepartamento de Neurobiologia Celular y Molecular, Laboratorio de Neurobiologia Molecular y Celular, Instituto de Neurobiologia, Campus UNAM Juriquilla, Queretaro, Qro CP76230, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDanio rerio is a powerful experimental model for studies in genetics and development. Recently, CRISPR technology has been applied in this species to mimic various human diseases, including those affecting the nervous system. Zebrafish offer multiple experimental advantages: external embryogenesis, rapid development, transparent embryos, short life cycle, and basic neurobiological processes shared with humans. This animal model, together with the CRISPR system, emerging imaging technologies, and novel behavioral approaches, lay the basis for a prominent future in neuropathology and will undoubtedly accelerate our understanding of brain function and its disorders.

objectiveGather relevant findings from studies that have used CRISPR technologies in zebrafish to explore basic neuronal function and model human diseases.

methodsWe systematically reviewed the most recent literature about CRISPR technology applications for understanding brain function and neurological disorders in D. rerio. We highlighted the key role of CRISPR in driving forward our understanding of particular topics in neuroscience.

resultsWe show specific advances in neurobiology when the CRISPR system has been applied in zebrafish and describe how CRISPR is accelerating our understanding of brain organization.

conclusionToday, CRISPR is the preferred method to modify genomes of practically any living organism. Despite the rapid development of CRISPR technologies to generate disease models in zebrafish, more efforts are needed to efficiently combine different disciplines to find the etiology and treatments for many brain diseases.

Indexed as

CRISPR-Cas SystemsDisease Models, AnimalNervous System DiseasesAnimalsGenomeZebrafishBrain disease modelsCRISPRDanio reriogenome engineeringoptogeneticszebrafish.

Identifiers

PMID31573887
PMCPMC7324878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.